Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KDM4A | O75164 | 2/20 | 0.52 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.52 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.51 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.51 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21908927 | 0.90 | LTA4H (0.62) | SMN1; SMN2KDM4AKDM4CSIGMAR1LTA4H | |
| SCHEMBL6878968 | 0.88 | KDM4A (0.65) | MEN1KMT2AKDM4AKDM4CSIGMAR1 | |
| SCHEMBL14028644 | 0.87 | SMN1; SMN2 (0.51) | SMN1; SMN2KDM4AKDM4CCARM1PRMT6 | |
| SCHEMBL40675 | 0.86 | KDM4A (0.66) | KMT2ASMN1; SMN2KDM4AKDM4CCARM1 | |
| SCHEMBL11559248 | 0.85 | SMN1; SMN2 (0.52) | SMN1; SMN2KDM4AKDM4CCARM1PRMT6 | |
| SCHEMBL3258895 | 0.85 | TDP1 (0.54) | TDP1LTA4HALDH1A1NPC1RAB9A | |
| SCHEMBL5175327 | 0.85 | TDP1 (0.54) | MEN1KMT2ATDP1LTA4HALDH1A1 | |
| SCHEMBL1303146 | 0.84 | LTA4H (0.62) | MEN1KMT2ASMN1; SMN2KDM4AKDM4C | |
| SCHEMBL5761072 | 0.83 | KDM4E (0.56) | MEN1KMT2ASMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL12358653 | 0.82 | TDP1 (0.52) | MEN1KMT2ATDP1LTA4HALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4145432-A | 6-ACYLORYALKYL-1,4-DIHYDROPYRIDINE DERIVATIVES AND A METHOD OF EFFECTING VASODILATION THEREWITH | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-20 | — | — | US | claimed |
| EP-3692372-B1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | HOFFMANN LA ROCHE (CH) | 2024-04-17 | — | — | EP | disclosed |
| US-11370756-B2 | Sulfoxide-based reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| US-11370756-B2 | Sulfoxide-based reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| EP-3692372-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | H. Hoffnabb-La Roche Ag (CH) | 2020-08-12 | — | — | EP | disclosed |
| US-20200199071-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2020-06-25 | — | — | US | disclosed |
| US-20200199071-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2020-06-25 | — | — | US | disclosed |
| WO-2019048450-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2019-03-14 | — | — | WO | disclosed |
| WO-2019048450-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2019-03-14 | — | — | WO | disclosed |
| EP-2590656-B1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX INC (US) | 2017-11-15 | — | — | EP | disclosed |
| US-8178712-B2 | Process for the synthesis of Ibandronate sodium | CIPLA LTD. (IN) | 2012-05-15 | — | — | US | disclosed |
| WO-2012054110-A2 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| WO-2012006475-A1 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | ARDELYX, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010116132-A2 | BISPHOSPHONATE COMPOUNDS FOR CHELATING RADIONUCLIDES | KING'S COLLEGE LONDON (GB) | 2010-10-14 | — | — | WO | disclosed |
| US-20100228052-A1 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD. (IN) | 2010-09-09 | — | — | US | disclosed |
| US-20100228052-A1 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD. (IN) | 2010-09-09 | — | — | US | disclosed |
| WO-2008035367-A2 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | CIPLA LTD. (IN) | 2008-03-27 | — | — | WO | disclosed |
| EP-0748310-B1 | DIESTERS OF CARBONIC ACID ENDOWED WITH ANTIVIRAL AND ANTI-INFLAMMATORY ACTIVITY | ITALFARMACO SPA (IT) | 1999-06-02 | — | — | EP | disclosed |
| US-5827881-A | ADMINISTERING FOR TREATMENT OF VIRAL DISEASES OR AS ANTIINFLAMMATORY AGENTS | ITALFARMACO S.P.A. (IT) | 1998-10-27 | — | — | US | disclosed |
| CN-1142222-A | Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity | ITALFARMACO SPA (IT) | 1997-02-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370756-B2 | Sulfoxide-based reagent for mass spectrometry | SRMS, MGMT, SQOR | MEN1 3188/4885KMT2A 2569/4885SMN1; SMN2 1127/4885 |
| US-20200199071-A1 | SULFOXIDE-BASED REAGENT FOR MASS SPECTROMETRY | SRMS, MGMT, SQOR | MEN1 3188/4885KMT2A 2569/4885SMN1; SMN2 1127/4885 |
| US-20100228052-A1 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM | BPGM, SQLE, GGPS1 | MEN1 876/4885KMT2A 3529/4885SMN1; SMN2 4264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.